Global Antiulcerant Drugs Market Research Report 2023

Report ID: 2006053 | Published Date: Jan 2025 | No. of Page: 82 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Antiulcerant Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Proton Pump Inhibitors
        1.2.3 H2 Receptor Antagonists
        1.2.4 Gastric Mucosal Protective Drugs
        1.2.5 Antibiotics
        1.2.6 Antacids
        1.2.7 Prostaglandin Agonists
    1.3 Market by Application
        1.3.1 Global Antiulcerant Drugs Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Mouth Ulcers
        1.3.3 Stomach Ulcers
        1.3.4 Leg Ulcer
        1.3.5 Esophageal Ulcer
        1.3.6 Bleeding Ulcer
        1.3.7 Neuropathic Ulcers
        1.3.8 Venous Stasis Ulcers
        1.3.9 Arterial (Ischemic) Ulcers
        1.3.10 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Antiulcerant Drugs Market Perspective (2018-2029)
    2.2 Antiulcerant Drugs Growth Trends by Region
        2.2.1 Global Antiulcerant Drugs Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Antiulcerant Drugs Historic Market Size by Region (2018-2023)
        2.2.3 Antiulcerant Drugs Forecasted Market Size by Region (2024-2029)
    2.3 Antiulcerant Drugs Market Dynamics
        2.3.1 Antiulcerant Drugs Industry Trends
        2.3.2 Antiulcerant Drugs Market Drivers
        2.3.3 Antiulcerant Drugs Market Challenges
        2.3.4 Antiulcerant Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Antiulcerant Drugs Players by Revenue
        3.1.1 Global Top Antiulcerant Drugs Players by Revenue (2018-2023)
        3.1.2 Global Antiulcerant Drugs Revenue Market Share by Players (2018-2023)
    3.2 Global Antiulcerant Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Antiulcerant Drugs Revenue
    3.4 Global Antiulcerant Drugs Market Concentration Ratio
        3.4.1 Global Antiulcerant Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Antiulcerant Drugs Revenue in 2022
    3.5 Antiulcerant Drugs Key Players Head office and Area Served
    3.6 Key Players Antiulcerant Drugs Product Solution and Service
    3.7 Date of Enter into Antiulcerant Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Antiulcerant Drugs Breakdown Data by Type
    4.1 Global Antiulcerant Drugs Historic Market Size by Type (2018-2023)
    4.2 Global Antiulcerant Drugs Forecasted Market Size by Type (2024-2029)
5 Antiulcerant Drugs Breakdown Data by Application
    5.1 Global Antiulcerant Drugs Historic Market Size by Application (2018-2023)
    5.2 Global Antiulcerant Drugs Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Antiulcerant Drugs Market Size (2018-2029)
    6.2 North America Antiulcerant Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Antiulcerant Drugs Market Size by Country (2018-2023)
    6.4 North America Antiulcerant Drugs Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Antiulcerant Drugs Market Size (2018-2029)
    7.2 Europe Antiulcerant Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Antiulcerant Drugs Market Size by Country (2018-2023)
    7.4 Europe Antiulcerant Drugs Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Antiulcerant Drugs Market Size (2018-2029)
    8.2 Asia-Pacific Antiulcerant Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Antiulcerant Drugs Market Size by Region (2018-2023)
    8.4 Asia-Pacific Antiulcerant Drugs Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Antiulcerant Drugs Market Size (2018-2029)
    9.2 Latin America Antiulcerant Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Antiulcerant Drugs Market Size by Country (2018-2023)
    9.4 Latin America Antiulcerant Drugs Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Antiulcerant Drugs Market Size (2018-2029)
    10.2 Middle East & Africa Antiulcerant Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Antiulcerant Drugs Market Size by Country (2018-2023)
    10.4 Middle East & Africa Antiulcerant Drugs Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Takeda Pharmaceutical
        11.1.1 Takeda Pharmaceutical Company Detail
        11.1.2 Takeda Pharmaceutical Business Overview
        11.1.3 Takeda Pharmaceutical Antiulcerant Drugs Introduction
        11.1.4 Takeda Pharmaceutical Revenue in Antiulcerant Drugs Business (2018-2023)
        11.1.5 Takeda Pharmaceutical Recent Development
    11.2 Eisai
        11.2.1 Eisai Company Detail
        11.2.2 Eisai Business Overview
        11.2.3 Eisai Antiulcerant Drugs Introduction
        11.2.4 Eisai Revenue in Antiulcerant Drugs Business (2018-2023)
        11.2.5 Eisai Recent Development
    11.3 Daewoong Pharmaceutical
        11.3.1 Daewoong Pharmaceutical Company Detail
        11.3.2 Daewoong Pharmaceutical Business Overview
        11.3.3 Daewoong Pharmaceutical Antiulcerant Drugs Introduction
        11.3.4 Daewoong Pharmaceutical Revenue in Antiulcerant Drugs Business (2018-2023)
        11.3.5 Daewoong Pharmaceutical Recent Development
    11.4 Allergan
        11.4.1 Allergan Company Detail
        11.4.2 Allergan Business Overview
        11.4.3 Allergan Antiulcerant Drugs Introduction
        11.4.4 Allergan Revenue in Antiulcerant Drugs Business (2018-2023)
        11.4.5 Allergan Recent Development
    11.5 AstraZeneca plc
        11.5.1 AstraZeneca plc Company Detail
        11.5.2 AstraZeneca plc Business Overview
        11.5.3 AstraZeneca plc Antiulcerant Drugs Introduction
        11.5.4 AstraZeneca plc Revenue in Antiulcerant Drugs Business (2018-2023)
        11.5.5 AstraZeneca plc Recent Development
    11.6 Valeant
        11.6.1 Valeant Company Detail
        11.6.2 Valeant Business Overview
        11.6.3 Valeant Antiulcerant Drugs Introduction
        11.6.4 Valeant Revenue in Antiulcerant Drugs Business (2018-2023)
        11.6.5 Valeant Recent Development
    11.7 Zydus
        11.7.1 Zydus Company Detail
        11.7.2 Zydus Business Overview
        11.7.3 Zydus Antiulcerant Drugs Introduction
        11.7.4 Zydus Revenue in Antiulcerant Drugs Business (2018-2023)
        11.7.5 Zydus Recent Development
    11.8 Shire
        11.8.1 Shire Company Detail
        11.8.2 Shire Business Overview
        11.8.3 Shire Antiulcerant Drugs Introduction
        11.8.4 Shire Revenue in Antiulcerant Drugs Business (2018-2023)
        11.8.5 Shire Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Antiulcerant Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Proton Pump Inhibitors
    Table 3. Key Players of H2 Receptor Antagonists
    Table 4. Key Players of Gastric Mucosal Protective Drugs
    Table 5. Key Players of Antibiotics
    Table 6. Key Players of Antacids
    Table 7. Key Players of Prostaglandin Agonists
    Table 8. Global Antiulcerant Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Antiulcerant Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 10. Global Antiulcerant Drugs Market Size by Region (2018-2023) & (US$ Million)
    Table 11. Global Antiulcerant Drugs Market Share by Region (2018-2023)
    Table 12. Global Antiulcerant Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 13. Global Antiulcerant Drugs Market Share by Region (2024-2029)
    Table 14. Antiulcerant Drugs Market Trends
    Table 15. Antiulcerant Drugs Market Drivers
    Table 16. Antiulcerant Drugs Market Challenges
    Table 17. Antiulcerant Drugs Market Restraints
    Table 18. Global Antiulcerant Drugs Revenue by Players (2018-2023) & (US$ Million)
    Table 19. Global Antiulcerant Drugs Market Share by Players (2018-2023)
    Table 20. Global Top Antiulcerant Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiulcerant Drugs as of 2022)
    Table 21. Ranking of Global Top Antiulcerant Drugs Companies by Revenue (US$ Million) in 2022
    Table 22. Global 5 Largest Players Market Share by Antiulcerant Drugs Revenue (CR5 and HHI) & (2018-2023)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Antiulcerant Drugs Product Solution and Service
    Table 25. Date of Enter into Antiulcerant Drugs Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Antiulcerant Drugs Market Size by Type (2018-2023) & (US$ Million)
    Table 28. Global Antiulcerant Drugs Revenue Market Share by Type (2018-2023)
    Table 29. Global Antiulcerant Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 30. Global Antiulcerant Drugs Revenue Market Share by Type (2024-2029)
    Table 31. Global Antiulcerant Drugs Market Size by Application (2018-2023) & (US$ Million)
    Table 32. Global Antiulcerant Drugs Revenue Market Share by Application (2018-2023)
    Table 33. Global Antiulcerant Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 34. Global Antiulcerant Drugs Revenue Market Share by Application (2024-2029)
    Table 35. North America Antiulcerant Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. North America Antiulcerant Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 37. North America Antiulcerant Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Europe Antiulcerant Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Europe Antiulcerant Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 40. Europe Antiulcerant Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 41. Asia-Pacific Antiulcerant Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Asia-Pacific Antiulcerant Drugs Market Size by Region (2018-2023) & (US$ Million)
    Table 43. Asia-Pacific Antiulcerant Drugs Market Size by Region (2024-2029) & (US$ Million)
    Table 44. Latin America Antiulcerant Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Latin America Antiulcerant Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Latin America Antiulcerant Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Middle East & Africa Antiulcerant Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 48. Middle East & Africa Antiulcerant Drugs Market Size by Country (2018-2023) & (US$ Million)
    Table 49. Middle East & Africa Antiulcerant Drugs Market Size by Country (2024-2029) & (US$ Million)
    Table 50. Takeda Pharmaceutical Company Detail
    Table 51. Takeda Pharmaceutical Business Overview
    Table 52. Takeda Pharmaceutical Antiulcerant Drugs Product
    Table 53. Takeda Pharmaceutical Revenue in Antiulcerant Drugs Business (2018-2023) & (US$ Million)
    Table 54. Takeda Pharmaceutical Recent Development
    Table 55. Eisai Company Detail
    Table 56. Eisai Business Overview
    Table 57. Eisai Antiulcerant Drugs Product
    Table 58. Eisai Revenue in Antiulcerant Drugs Business (2018-2023) & (US$ Million)
    Table 59. Eisai Recent Development
    Table 60. Daewoong Pharmaceutical Company Detail
    Table 61. Daewoong Pharmaceutical Business Overview
    Table 62. Daewoong Pharmaceutical Antiulcerant Drugs Product
    Table 63. Daewoong Pharmaceutical Revenue in Antiulcerant Drugs Business (2018-2023) & (US$ Million)
    Table 64. Daewoong Pharmaceutical Recent Development
    Table 65. Allergan Company Detail
    Table 66. Allergan Business Overview
    Table 67. Allergan Antiulcerant Drugs Product
    Table 68. Allergan Revenue in Antiulcerant Drugs Business (2018-2023) & (US$ Million)
    Table 69. Allergan Recent Development
    Table 70. AstraZeneca plc Company Detail
    Table 71. AstraZeneca plc Business Overview
    Table 72. AstraZeneca plc Antiulcerant Drugs Product
    Table 73. AstraZeneca plc Revenue in Antiulcerant Drugs Business (2018-2023) & (US$ Million)
    Table 74. AstraZeneca plc Recent Development
    Table 75. Valeant Company Detail
    Table 76. Valeant Business Overview
    Table 77. Valeant Antiulcerant Drugs Product
    Table 78. Valeant Revenue in Antiulcerant Drugs Business (2018-2023) & (US$ Million)
    Table 79. Valeant Recent Development
    Table 80. Zydus Company Detail
    Table 81. Zydus Business Overview
    Table 82. Zydus Antiulcerant Drugs Product
    Table 83. Zydus Revenue in Antiulcerant Drugs Business (2018-2023) & (US$ Million)
    Table 84. Zydus Recent Development
    Table 85. Shire Company Detail
    Table 86. Shire Business Overview
    Table 87. Shire Antiulcerant Drugs Product
    Table 88. Shire Revenue in Antiulcerant Drugs Business (2018-2023) & (US$ Million)
    Table 89. Shire Recent Development
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Antiulcerant Drugs Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Antiulcerant Drugs Market Share by Type: 2022 VS 2029
    Figure 3. Proton Pump Inhibitors Features
    Figure 4. H2 Receptor Antagonists Features
    Figure 5. Gastric Mucosal Protective Drugs Features
    Figure 6. Antibiotics Features
    Figure 7. Antacids Features
    Figure 8. Prostaglandin Agonists Features
    Figure 9. Global Antiulcerant Drugs Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 10. Global Antiulcerant Drugs Market Share by Application: 2022 VS 2029
    Figure 11. Mouth Ulcers Case Studies
    Figure 12. Stomach Ulcers Case Studies
    Figure 13. Leg Ulcer Case Studies
    Figure 14. Esophageal Ulcer Case Studies
    Figure 15. Bleeding Ulcer Case Studies
    Figure 16. Neuropathic Ulcers Case Studies
    Figure 17. Venous Stasis Ulcers Case Studies
    Figure 18. Arterial (Ischemic) Ulcers Case Studies
    Figure 19. Others Case Studies
    Figure 20. Antiulcerant Drugs Report Years Considered
    Figure 21. Global Antiulcerant Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 22. Global Antiulcerant Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 23. Global Antiulcerant Drugs Market Share by Region: 2022 VS 2029
    Figure 24. Global Antiulcerant Drugs Market Share by Players in 2022
    Figure 25. Global Top Antiulcerant Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiulcerant Drugs as of 2022)
    Figure 26. The Top 10 and 5 Players Market Share by Antiulcerant Drugs Revenue in 2022
    Figure 27. North America Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. North America Antiulcerant Drugs Market Share by Country (2018-2029)
    Figure 29. United States Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Canada Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Europe Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Europe Antiulcerant Drugs Market Share by Country (2018-2029)
    Figure 33. Germany Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. France Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. U.K. Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Italy Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Russia Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Nordic Countries Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Asia-Pacific Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Asia-Pacific Antiulcerant Drugs Market Share by Region (2018-2029)
    Figure 41. China Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Japan Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. South Korea Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Southeast Asia Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. India Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Australia Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Latin America Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Latin America Antiulcerant Drugs Market Share by Country (2018-2029)
    Figure 49. Mexico Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 50. Brazil Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 51. Middle East & Africa Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 52. Middle East & Africa Antiulcerant Drugs Market Share by Country (2018-2029)
    Figure 53. Turkey Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Saudi Arabia Antiulcerant Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. Takeda Pharmaceutical Revenue Growth Rate in Antiulcerant Drugs Business (2018-2023)
    Figure 56. Eisai Revenue Growth Rate in Antiulcerant Drugs Business (2018-2023)
    Figure 57. Daewoong Pharmaceutical Revenue Growth Rate in Antiulcerant Drugs Business (2018-2023)
    Figure 58. Allergan Revenue Growth Rate in Antiulcerant Drugs Business (2018-2023)
    Figure 59. AstraZeneca plc Revenue Growth Rate in Antiulcerant Drugs Business (2018-2023)
    Figure 60. Valeant Revenue Growth Rate in Antiulcerant Drugs Business (2018-2023)
    Figure 61. Zydus Revenue Growth Rate in Antiulcerant Drugs Business (2018-2023)
    Figure 62. Shire Revenue Growth Rate in Antiulcerant Drugs Business (2018-2023)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Takeda Pharmaceutical
Eisai
Daewoong Pharmaceutical
Allergan
AstraZeneca plc
Valeant
Zydus
Shire
Frequently Asked Questions
Antiulcerant Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Antiulcerant Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Antiulcerant Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Anti-Parkinson Drugs

This report aims to provide a comprehensive presentation of the global market for Anti-Parkinson  ... Read More